Top Tech Companies in Tampa, FL (1,401)

Resilient & Sustainable Growth: Revenue has increased year over year to a new high, with all three major service lines posting gains despite a slower pace. Growth remains uneven by region, but the overall trajectory is upward over the last several fiscal years.

Future-Ready Strategy: Multi‑billion‑dollar investments in technology—especially nearly $1.5B in AI—along with acquisitions and scaling managed services indicate a deliberate pivot to future growth levers. Leadership attention to next‑generation audit and AI‑enabled capabilities underscores preparation for emerging demand.

Strong Market Position & Advantage: The organization is characterized as a leading global professional‑services network with broad scale across assurance, advisory, and tax and repeated external recognitions in select consulting categories. Reach across major multinational clients supports durable competitive positioning.

Market Expansion: International presence is expanding with a new U.K. headquarters and local leadership in multiple new markets, alongside three multi-year contracts totaling about $204.7M across the Middle East and Africa and more than a dozen new European customers in 2025. Company materials also describe broadened relationships across U.S. government, international government, and commercial customers.

Product Line Growth: The business is moving beyond satellite imagery into an end-to-end, software-driven spatial-intelligence platform with offerings such as Tensorglobe, Cortex, Forge, Nexus, and new releases like WorldView 3D. Constellation plans (Vantage and Pulse) further extend scope toward higher-resolution and high-revisit capabilities.

Strategic Partnerships: Partnerships with BAE Systems, EnduroSat, and CACI underpin next-generation satellites, while collaborations with Esri, Google, Rheinmetall, and Anduril expand distribution and solution integration. These alliances indicate deeper ecosystem reach across defense and commercial geospatial workflows.

Investor Backing & Capital Strength: Surplus increased year over year and independent agencies affirmed top-tier financial strength, indicating a reinforced capital base. This combination points to resilient capacity to support growth and policyholder commitments.

Profitability: Operating earnings rose across 2023–2025, with another increase in 2025. Record dividend declarations further reflect durable earnings power within a mutual structure.

Diversified Revenue Streams: Sales expanded broadly across insurance, annuities, and mutual funds in 2025. Assets under management also grew, reinforcing multiple business engines contributing to expansion.

Strong Revenue Growth: Premiums, fees and other revenues increased 10% in 2025 to $57.6B, then rose 5% in Q1 2026 and 7% in Q2 2026. Adjusted PFOs excluding pension risk transfers were up about 5% in Q2 2026, with growth reported across every operating segment.

Profitability: Adjusted EPS increased 10% in 2025, while adjusted earnings grew 18% in Q1 2026 and 15% in Q2 2026, indicating earnings outpacing revenue growth. The company also reported mid‑teens adjusted ROE in 2026.

Healthy Cash Flow: The company produced nearly $5 billion in free cash flow in 2025 and returned about $4.4 billion to shareholders. A new $3 billion repurchase authorization alongside ongoing dividends underscores continued cash generation and capital strength.

Strong Revenue Growth: Company statements describe being on track for higher net revenue, and earlier filings documented substantial year-over-year expansion. Additional references point to rising contribution metrics over recent years.

Customer Loyalty & Retention: Company updates highlight record-high satisfaction and retention alongside a recent step-up in new-customer signups. These signals point to a stable, expanding customer base.

Product Line Growth: The business continues broadening its offering beyond core PEO into payroll, benefits, HR tools, and international employment, described under a “One Justworks” strategy. New capabilities and partnerships indicate ongoing investment in breadth.

Product Line Growth: Growth in medicines such as Eliquis, Padcev, the Vyndaqel family, Lorbrena, Nurtec/Vydura and oncology biosimilars more than offset part of the COVID-related decline in the first half of 2026. Launched and acquired products also delivered strong double‑digit operational gains in Q2 2026.

Resilient & Sustainable Growth: Underlying revenue excluding COVID products advanced at a mid‑single‑digit pace in 2025 and the first half of 2026, while total revenue returned to modest year‑over‑year growth in early 2026. Management raised the midpoint of 2026 revenue guidance, signaling improving momentum beneath headline totals.

Future-Ready Strategy: Heavy investment in a broad late‑stage pipeline and plans for numerous pivotal study starts in 2026 support longer‑term growth. Continued business development and integration of acquired assets are positioned to offset COVID normalization and loss‑of‑exclusivity pressures over time.

Profitability: Bottom-line performance is strengthening, with consistent earnings beats, improved non-GAAP operating income, and durable free cash flow. Management is prioritizing margin expansion alongside operational efficiency.

Healthy Cash Flow: The business is generating solid free cash flow, with recent periods and guidance pointing to sustained cash generation. This supports stability even as revenue growth moderates.

Strong Market Position & Advantage: The company is repeatedly recognized as a leader in MDR, exposure management, and SIEM by major analyst programs. A large global customer base underscores established scale in its core markets.

Strong Revenue Growth: Top-line revenue is reported to have grown strongly on a multi-year basis through 2023, with additional indications of continued increases into 2025–2026. This provides the clearest quantitative signal of momentum for a private company with limited disclosures.

Market Expansion: The provider network and product footprint have broadened, including new launches such as programmatic access and a consumer health media offering alongside partnerships that extend reach. These moves show growth beyond core point-of-care screens into adjacent adtech and consumer channels.

Investor Backing & Capital Strength: Advent International’s 2025 agreement to acquire the company and continued investment signal substantial sponsor support for scaling. Such backing typically underwrites further network growth and product innovation.

Strong Revenue Growth: Company-reported revenue around $2.7B in 2025 with a Q4 run-rate near $3B, and leadership indicating a >$4B run-rate in 2026, point to ongoing scale gains. Freight volume rising roughly 25% in 2024 and more than 20% year over year in 2025 reinforces the upward trajectory.

Investor Backing & Capital Strength: A majority equity investment by Mubadala Capital is presented as fueling the next phase of growth without adding deal-related debt. The transaction is tied to expanding services, technology, and talent, including plans to hire 1,000 people in 2026.

Strong Hiring & Retention: Headcount moved past 2,000 with 500 hires in 2024 and 650 in 2025, with roughly 1,000 additional hires planned for 2026. Company updates also cite record‑low attrition alongside productivity gains.

Strong Revenue Growth: Disclosures indicate revenue grew 137% in 2024 and 160% in the first nine months of 2025, reaching $783.7M for that period. Gains in average daily client balances and trading volume further underscore broad-based top-line acceleration.

Profitability: Net income turned meaningfully positive, with $89.1M in 2024 and $157.2M in the first nine months of 2025. This profitability alongside rapid scaling supports financial stability.

Market Expansion: The company expanded beyond U.S. prime brokerage into UK and European equities (e.g., LSE clearing membership) and pursued APAC access via regulatory approvals and acquisitions. It also broadened offerings across futures, fixed income, options, digital assets, and investment banking.

Strong Revenue Growth: Evidence indicates the business scaled rapidly pre-acquisition, with approximately $900 million in 2023 bedding sales and its trajectory characterized as “hyper-growth.” Post-acquisition materials frame the combination as designed to accelerate growth, though standalone revenue is not broken out.

Investor Backing & Capital Strength: Ashley’s nearly $1 billion acquisition (about $680 million in cash plus a $300 million seller note) signals substantial capital support and confidence in the unit’s scale. Operating under Ashley Digital further implies sustained financial backing from a large private parent.

Market Expansion: The deal was positioned to deliver broader assortment, sourcing efficiencies, and a larger global footprint to grow both DTC and wholesale channels. Brands are distributed through thousands of retail partners across the U.S., Canada, and the U.K., alongside access to Ashley’s 1,100+ store network.

Strong Revenue Growth: Results show net sales rebounded in 2025 and accelerated further into early 2026, with consecutive year-over-year increases and stronger momentum in the first half. Evidence indicates the top line is rising at a faster pace than in recent years.

Diversified Customer Base: Growth is spread across Commercial, Government, Education (albeit modest), and international operations, indicating multiple end markets are contributing. This dispersion suggests the upturn is not reliant on a single segment.

Product Line Growth: Software and services expanded year over year alongside hardware, pointing to a broader mix of offerings. Feedback suggests the portfolio is deepening beyond traditional resell categories.

Market Expansion: Additions of sales-agent coverage across Texas/Arkansas/Oklahoma, the Northeast/NYC/NJ, and the Mountain West in 2026, plus growth to 18 North American locations with larger facilities (e.g., a 285,000+ sq.-ft. Atlanta site, a 200,000-sq.-ft. Tampa site, and a new Mississauga branch), point to broader reach. The completed Kingwire acquisition adds eight warehouses and more than 625,000 sq. ft., further densifying the network.

Product Line Growth: A dedicated Communications Business Unit and expanded industrial automation/communications portfolio, combined with Kingwire’s strengths in aluminum, utility, data centers, and renewables, indicate a broadened offering. Approximately $400M of stated inventory supports availability across the enlarged SKU set.

Investor Backing & Capital Strength: Completion of the 2026 Kingwire acquisition alongside maintaining roughly $400M of inventory and major facility investments suggests access to capital to fund scale. Backing from Dot Family Holdings and prior acquisitions reinforce the platform’s capital support.

Investor Backing & Capital Strength: A growth-oriented private equity investment from New Mountain Capital (with minority investments from CDPQ and OA Private Capital) in 2024 supplied an “investment war chest” to accelerate technology, AI-enabled services, talent acquisition, and strategic expansion. This capital base also underpins the multinational platform strategy and the announced CBIZ deal.

Market Expansion: Grant Thornton Advisors announced a $5.0 billion acquisition of CBIZ that, upon closing, would lift the U.S. platform past $5 billion in domestic revenue and expand brand reach. The Advisors arm also combined with Grant Thornton Ireland in 2025 and has since grown its European footprint, signaling inorganic and international momentum.

Strong Market Position & Advantage: The firm is consistently ranked among the top U.S. accounting and professional services firms, operates across numerous U.S. offices, and is a premier leader for the mid‑market and private‑equity segments. Its inclusion among the small set of firms subject to annual PCAOB inspection underscores national scale and capital‑markets relevance.